Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

World's largest BPH registry launches to track surgical success

NCT ID NCT05543200

Knowledge-focused Sponsor: Société Internationale d'Urologie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This study is creating a worldwide registry to track how well different surgical treatments work for benign prostatic hyperplasia (BPH), a condition where the prostate gland enlarges and causes urinary problems. Researchers will collect data from 7,500 participants to compare symptom relief, quality of life, and complications over time. The goal is to provide real-world evidence to help doctors choose the best treatments for their patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 7,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2023

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients \>18 years with symptomatic BPH with LUTS who are planned for medical or surgical intervention are eligible for this study.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention Exclusion Criteria: * Non-symptomatic BPH * No treatment prescribed for BPH

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Lower Urinary Tract Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Benign prostatic hyperplasia Lower urinary tract symptoms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    30 sites in 21 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ahmadu Bello University Teaching Hospital

    RECRUITING

    Zaria, Nigeria

  • American University of Beirut

    RECRUITING

    Beirut, Lebanon

  • Azienda Ospedaliero-Universitaria Careggi

    RECRUITING

    Florence, Italy

  • Benue State University Teaching Hospital, Department of Surgery

    RECRUITING

    Makurdi, Nigeria

  • Centro Medico Nacional Siglo XXI

    RECRUITING

    Mexico City, Mexico

  • Dr Baba Saheb Ambedkar Medical College and Hospital

    RECRUITING

    Delhi, India

  • Gracepark Medical Centre

    NOT_YET_RECRUITING

    Meru, Kenya

  • Hamad Medical Corporation Qatar

    RECRUITING

    Doha, Qatar

  • Hospital Dr. Juan Morey La Unión

    RECRUITING

    La Unión, Chile

  • Hospital del Trabajador

    RECRUITING

    Santiago, Chile

  • Imperial College Healthcare NHS Trust

    NOT_YET_RECRUITING

    London, United Kingdom

  • Institute of Kidney Diseases Peshawar

    RECRUITING

    Peshawar, Pakistan

  • Istanbul Medipol University

    RECRUITING

    Istanbul, Turkey (Türkiye)

  • Kati University Hospital

    RECRUITING

    Kati, Mali

  • Keck Medicine of USC

    RECRUITING

    Los Angeles, California, 90089, United States

  • Kenyatta National Hospital

    NOT_YET_RECRUITING

    Nairobi, Kenya

  • Lady Reading Hospital

    RECRUITING

    Peshawar, Pakistan

  • McGill University Health Centre

    RECRUITING

    Montreal, Quebec, Canada

  • Pandya Memorial Hospital

    NOT_YET_RECRUITING

    Mombasa, Kenya

  • Sapienza University of Rome, Division of Urology, Ospedale Sant'Andrea

    RECRUITING

    Rome, Italy

  • Seoul National University Bundang Hospital

    NOT_YET_RECRUITING

    Seongnam, South Korea

  • Shariati Hospital

    RECRUITING

    Tehran, Iran

  • Southend University Hospital

    RECRUITING

    Southend-on-Sea, United Kingdom

  • The Chinese University of Hong Kong

    NOT_YET_RECRUITING

    Hong Kong, Hong Kong

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, China

  • Toronto Western Hospital, University Health Network

    RECRUITING

    Toronto, Ontario, Canada

  • Universiti Malaya

    RECRUITING

    Kuala Lumpur, Malaysia

  • University of Basrah

    RECRUITING

    Basra, Iraq

  • University of Cyprus

    NOT_YET_RECRUITING

    Nicosia, Cyprus

  • University of Montreal Hospital Center

    NOT_YET_RECRUITING

    Montreal, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.